Data Characteristics
R&D documents for neurodegenerative diseases originate from clinical trial reports, pathology analysis reports, gene sequencing data, drug mechanism of action research papers, and various bioinformatics databases. Data update frequencies vary. Clinical trial reports and research papers update with project progress or journal publications. Genomic databases may update monthly or quarterly in batches. Document structures are diverse, ranging from standardized clinical trial protocols (e.g., ICH-GCP format) to unstructured research notes and experimental records. Common fields include patient ID, disease stage (e.g., MMSE score), biomarker concentrations (e.g., Aβ42/Tau ratio, in pg/mL), gene mutation sites (e.g., APOE ε4 allele), drug dosage (in mg/kg), and target of action.
Constraints on Reference Tracing
The complexity of neurodegenerative disease R&D documents imposes specific requirements on reference tracing. First, the wide range of data sources necessitates integrating multiple knowledge bases. For example, one knowledge base may contain clinical trial data, while another stores genomic information. Second, diverse document structures require the RAG system to process various input formats, from structured tables to unstructured text, ensuring accurate information extraction. The specificity of fields and units, such as Aβ42/Tau ratio or MMSE score, requires the system to precisely identify and associate these specialized terms and their values during citation, avoiding semantic confusion. Varying update frequencies, especially for rapidly iterating genomic data, demand that knowledge base indexing supports incremental updates to ensure citation timeliness. Furthermore, strict data source traceability is a compliance requirement due to patient privacy and ethical considerations.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Recall count | 5–8 | The complexity of neurodegenerative disease R&D documents requires more contextual associations to ensure semantic completeness. |
Similarity threshold | 0.75–0.85 | Precisely match specialized terms and numerical values, avoiding the introduction of irrelevant biomedical concepts. |
Chunk size | 800–1200 characters | Ensure each segment contains sufficient contextual information, covering experimental methods, results, and discussion. |
Rerank result count | Top 3 | Further filter the most relevant and highly weighted reference content based on initial recall. |
maxContext | 8000–12000 tokens | Accommodate detailed descriptions of disease mechanisms, drug actions, and clinical manifestations, ensuring deep large model understanding. |
Knowledge Base Citation Settings | Associate multiple knowledge bases | Integrate multi-dimensional data (clinical, genomic, pathological) to provide comprehensive traceability. |
Common Pitfalls
- Phenomenon: Large model responses cite biomarker values that do not match the original text or have incorrect units. Reason: The knowledge base segmentation strategy is too coarse, leading to values and units being separated across different segments, or the parser fails to correctly identify specialized units.
- Phenomenon: After calling the knowledge base, the workflow cannot cite the expected gene mutation site information. Reason: The knowledge base index does not include synonyms or variants for such specialized terms, leading to recall failure, or the tool lacks necessary context parameter passing when connecting to the knowledge base.
- Phenomenon: System response time significantly increases, especially when querying complex disease pathways involving a large number of documents. Reason: The
Recall countsetting is too large, causing the context token amount submitted to the large language model for each query to exceed actual needs, affecting model processing efficiency.
Validation
- Manually verify typical queries. Confirm that key information such as biomarker concentrations, gene mutation sites, and drug dosages in the citations precisely match the original documents, including values and units.
- Construct test cases for different data sources (e.g., clinical reports, gene sequencing reports). Confirm the system can accurately recall and cite relevant information from each knowledge base.
- Monitor system logs and performance metrics. Observe the average response time for knowledge base queries. Compare it with the baseline after adjusting
Recall countandmaxContextto ensure performance remains within an acceptable range.
The values given are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.